Tag Archives: Aclidinium monotherapyunder

Spanish pharmaceutical company Almirall released its H1 2013 financial results

Posted on 5, August 2013 by EuropaWire PR Editors

Barcelona, 05-8-2013 — /EuropaWire/ — Almirall’s H1: Executing on growth platforms, financial delivery on track Financial performance in line with guidance Aclidinium now available in 13 countries with five new launches planned before year’s end US/EU filings of aclidinium/formoterol combination are … Read the full press release →

Posted in Business, Financial, Healthcare, Investment, Pharma & Biotech, Science, Spain

Tagged Aclidinium, Aclidinium monotherapyunder, aclidinium/formoterol combination, Alejandra Ríos, ALM, Almirall, Almirall financial results, Barcelona, Bretaris®, Constella®, COPD market, dermatology diseases, Eduardo Sanchiz, Eklira®, founded in 1943, gastroenterology diseases, Jordi Molina, LAMA market, respiratory diseases, Sonia San Segundo, Spanish Stock Exchange